Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Authors
Keywords
-
Journal
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-14
DOI
10.1007/s12035-021-02696-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning
- (2021) Gabriel A. Erausquin et al. Alzheimers & Dementia
- 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
- (2021) Chaolin Huang et al. LANCET
- COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation
- (2021) Mohamed M. Aboudounya et al. MEDIATORS OF INFLAMMATION
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Immune determinants of COVID-19 disease presentation and severity
- (2021) Petter Brodin NATURE MEDICINE
- Central nervous system manifestations in COVID‐19 patients: A systematic review and meta‐analysis
- (2021) Shahrzad Nazari et al. Brain and Behavior
- Novel Targets of SARS-CoV-2 Spike Protein in Human Fetal Brain Development Suggest Early Pregnancy Vulnerability
- (2021) Parul Varma et al. Frontiers in Neuroscience
- Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
- (2021) Angela E. Peter et al. Frontiers in Pharmacology
- Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019
- (2021) Otávio M. Espíndola et al. ANNALS OF NEUROLOGY
- Integration of heparin-binding protein and interleukin-6 in the early prediction of respiratory failure and mortality in pneumonia by SARS-CoV-2 (COVID-19)
- (2021) Maria Saridaki et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- An in-silico approach to identify the potential hot spots in SARS-CoV-2 spike RBD to block the interaction with ACE2 receptor
- (2021) Antony Stalin et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Luteolin inhibits NLRP3 inflammasome activation via blocking ASC oligomerization
- (2021) Mi Nam Lee et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies
- (2021) Amira Mohammed Ali et al. MOLECULES
- Attributes and predictors of long COVID
- (2021) Carole H. Sudre et al. NATURE MEDICINE
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing Brain Capillaries in Coronavirus Disease 2019
- (2021) David W. Nauen et al. JAMA Neurology
- Manifestations and impact of the COVID‐19 pandemic in neuroinflammatory diseases
- (2021) Seth N. Levin et al. Annals of Clinical and Translational Neurology
- Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
- (2021) Theoharis C. Theoharides et al. BIOFACTORS
- SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
- (2021) Yuyang Lei et al. CIRCULATION RESEARCH
- Neuropathogenesis of acute coronavirus disease 2019
- (2021) Shelli F. Farhadian et al. CURRENT OPINION IN NEUROLOGY
- Editorial of Special Issue “Regulatory Roles of Inflammasomes in Human Diseases”
- (2021) Young-Su Yi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Can nutraceuticals assist treatment and improve covid-19 symptoms?
- (2021) Alessio Alesci et al. NATURAL PRODUCT RESEARCH
- Post-acute COVID-19 syndrome
- (2021) Ani Nalbandian et al. NATURE MEDICINE
- Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein
- (2021) Jessica Gasparello et al. PHYTOMEDICINE
- Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS‐CoV ‐2
- (2021) Abhishek Gour et al. PHYTOTHERAPY RESEARCH
- SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents
- (2021) Anna Fagre et al. PLoS Pathogens
- SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
- (2021) Andrew G Letizia et al. Lancet Respiratory Medicine
- SARS-CoV-2 targets glial cells in human cortical organoids
- (2021) Courtney L. McMahon et al. Stem Cell Reports
- Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection
- (2021) Menizibeya O. Welcome et al. INFLAMMOPHARMACOLOGY
- Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
- (2021) Edith L. Graham et al. Annals of Clinical and Translational Neurology
- Interleukin-6 Inhibition Reduces Neuronal Injury In A Murine Model of Ventilator-Induced Lung Injury
- (2021) Nicklaus A. Sparrow et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
- (2021) Alana F Ogata et al. CLINICAL INFECTIOUS DISEASES
- Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant
- (2021) Susmit Mhatre et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Targeting neuropilins as a viable SARS‐CoV‐2 treatment
- (2021) Sarvenaz Sarabipour et al. FEBS Journal
- Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening
- (2021) Yuan Xiong et al. FITOTERAPIA
- Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
- (2021) Nouara Yahi et al. JOURNAL OF INFECTION
- A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications
- (2021) Jennifer A. Frontera et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells
- (2021) Keith Meyer et al. JOURNAL OF VIROLOGY
- Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease
- (2021) HariOm Singh et al. MICROBIAL PATHOGENESIS
- Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19
- (2021) Ying-Qi Wang et al. MOLECULES
- Dysregulation of brain and choroid plexus cell types in severe COVID-19
- (2021) Andrew C. Yang et al. NATURE
- SARS-CoV-2 takes its Toll
- (2021) Alan Sariol et al. NATURE IMMUNOLOGY
- Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
- (2021) Evdoxia Kyriazopoulou et al. NATURE MEDICINE
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- Unravelling Pathophysiology of Neurological and Psychiatric Complications of COVID-19 Using Brain Organoids
- (2021) Jing-Han Ng et al. NEUROSCIENTIST
- Confronting Our Next National Health Disaster — Long-Haul Covid
- (2021) Steven Phillips et al. NEW ENGLAND JOURNAL OF MEDICINE
- Flavonoids are promising safe therapy against COVID-19
- (2021) Moza Mohamed Alzaabi et al. PHYTOCHEMISTRY REVIEWS
- Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT
- (2021) Melanie L. Bell et al. PLoS One
- The impact of the COVID-19 pandemic on cerebrovascular disease
- (2021) David I. Bass et al. Seminars in Vascular Surgery
- Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO
- (2021) Gabriel Jiménez-Avalos et al. Scientific Reports
- Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2
- (2021) Lin Liu et al. ACS Central Science
- The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review
- (2021) Monika Gudowska-Sawczuk et al. Journal of Clinical Medicine
- Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses
- (2021) Jacob K. Files et al. JCI Insight
- Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19
- (2021) Souparnika H. Manjunath et al. Journal of Pharmaceutical Analysis
- SARS-CoV-2: is there neuroinvasion?
- (2021) Conor McQuaid et al. Fluids and Barriers of the CNS
- Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer
- (2021) Jingwen Yue et al. Frontiers in Molecular Biosciences
- Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder
- (2021) Theoharis C. Theoharides Journal of Personalized Medicine
- SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity
- (2021) Somasundaram Raghavan et al. Frontiers in Cardiovascular Medicine
- Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
- (2021) Francesco Di Pierro et al. International Journal of General Medicine
- The Relationship Between Perceived Stress and Subjective Cognitive Decline During the COVID-19 Epidemic
- (2021) Anja Podlesek et al. Frontiers in Psychology
- SARS-CoV-2-related Progressive Brain White Matter Lesion Associated with an Increased Cerebrospinal Fluid Level of IL-6
- (2021) Yuwa Oka et al. INTERNAL MEDICINE
- Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?
- (2021) Ives Charlie-Silva et al. JOURNAL OF HAZARDOUS MATERIALS
- In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals
- (2021) Yusuf Şimşek et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- SARS-CoV-2 Spike Protein Disrupts Blood–Brain Barrier Integrity via RhoA Activation
- (2021) Brandon J. DeOre et al. Journal of Neuroimmune Pharmacology
- Molecular docking of SARS-COV-2 Spike epitope sequences identifies heterodimeric peptide-protein complex formation with human Zo-1, TLR8 and brain specific glial proteins
- (2021) Subhajit Dasgupta et al. MEDICAL HYPOTHESES
- SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein
- (2021) Rayan Khaddaj-Mallat et al. NEUROBIOLOGY OF DISEASE
- Waning Immunity after the BNT162b2 Vaccine in Israel
- (2021) Yair Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination
- (2021) William J. Murphy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells
- (2021) Eun Seon Kim et al. Viruses-Basel
- Effect of SARS-CoV-2 proteins on vascular permeability
- (2021) Rossana Rauti et al. eLife
- Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients
- (2021) Shobi Veleri EXPERIMENTAL BRAIN RESEARCH
- Anti–SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms
- (2021) Christopher M. Bartley et al. JAMA Neurology
- SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems
- (2021) Anne G. Savitt et al. Frontiers in Immunology
- Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
- (2021) Ruby A. Escobedo et al. Frontiers in Immunology
- Characterizing Long COVID: Deep Phenotype of a Complex Condition
- (2021) Rachel R Deer et al. EBioMedicine
- Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials
- (2021) Dimitrios Sagris et al. Journal of Clinical Medicine
- Extra Virgin Olive Oil Polyphenols: Modulation of Cellular Pathways Related to Oxidant Species and Inflammation in Aging
- (2020) Gabriele Serreli et al. Cells
- Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms
- (2020) Abdul Mannan Baig et al. ACS Chemical Neuroscience
- COVID ‐19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
- (2020) Theoharis C. Theoharides BIOFACTORS
- The COVID-19 Pandemic: Setting the Mental Health Research Agenda
- (2020) Joshua A. Gordon et al. BIOLOGICAL PSYCHIATRY
- COVID-19 pandemic and mental health consequences: systematic review of the current evidence
- (2020) Nina Vindegaard et al. BRAIN BEHAVIOR AND IMMUNITY
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- COVID-19 and Depression
- (2020) Richard I. Shader CLINICAL THERAPEUTICS
- The mechanistic target of rapamycin (mTOR): Novel Considerations as an Antiviral Treatment and Possibilities for COVID-19
- (2020) Kenneth Maiese CURRENT NEUROVASCULAR RESEARCH
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
- (2020) Tobias Herold et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunoregulation with mTOR inhibitors to prevent COVID‐19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines
- (2020) Yunfeng Zheng et al. JOURNAL OF MEDICAL VIROLOGY
- APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
- (2020) Axel Montagne et al. NATURE
- Neurologic Features in Severe SARS-CoV-2 Infection
- (2020) Julie Helms et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness
- (2020) Benjamin G. Druss JAMA Psychiatry
- Considerations around the SARS-CoV-2 Spike Protein with Particular Attention to COVID-19 Brain Infection and Neurological Symptoms
- (2020) Kambiz Hassanzadeh et al. ACS Chemical Neuroscience
- What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications?
- (2020) Lena Al-Harthi et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- COVID ‐19: A Global Threat to the Nervous System
- (2020) Igor J. Koralnik et al. ANNALS OF NEUROLOGY
- Neurobiology of COVID-19
- (2020) Majid Fotuhi et al. JOURNAL OF ALZHEIMERS DISEASE
- Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
- (2020) Alessio Mazzoni et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19
- (2020) Fang Liu et al. JOURNAL OF CLINICAL VIROLOGY
- Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports
- (2020) Souhel Najjar et al. Journal of Neuroinflammation
- Neurological associations of COVID-19
- (2020) Mark A Ellul et al. LANCET NEUROLOGY
- COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
- (2020) Duraisamy Kempuraj et al. NEUROSCIENTIST
- Mental Health and the Covid-19 Pandemic
- (2020) Betty Pfefferbaum et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 and the Immune System
- (2020) J PACES et al. PHYSIOLOGICAL RESEARCH
- Distinct conformational states of SARS-CoV-2 spike protein
- (2020) Yongfei Cai et al. SCIENCE
- Transplacental transmission of SARS-CoV-2 infection
- (2020) Alexandre J. Vivanti et al. Nature Communications
- Neuropathogenesis of SARS-CoV-2 infection
- (2020) Shumayila Khan et al. eLife
- Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
- (2020) Yujun Tang et al. Frontiers in Immunology
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia
- (2020) David H. Brann et al. Science Advances
- Severe COVID-19: A multifaceted viral vasculopathy syndrome
- (2020) Cynthia M. Magro et al. Annals of Diagnostic Pathology
- Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma
- (2020) Duraisamy Kempuraj et al. BIOFACTORS
- Roles of flavonoids against coronavirus infection
- (2020) Maria Russo et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Coronavirus 2019, Microthromboses, and Platelet Activating Factor
- (2020) Theoharis C. Theoharides et al. CLINICAL THERAPEUTICS
- SARS ‐CoV‐2 targets neurons of 3D human brain organoids
- (2020) Anand Ramani et al. EMBO JOURNAL
- Psychiatry and COVID-19
- (2020) Dost Öngür et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Highways to hell: mechanism based management of Cytokine Storm Syndromes
- (2020) Scott W. Canna et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
- (2020) Ana Copaescu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Chronic COVID Syndrome: Need for an appropriate medical terminology for Long‐COVID and COVID Long‐Haulers
- (2020) Abdul Mannan Baig JOURNAL OF MEDICAL VIROLOGY
- COVID-19: dealing with a potential risk factor for chronic neurological disorders
- (2020) Tommaso Schirinzi et al. JOURNAL OF NEUROLOGY
- Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease
- (2020) Mohammad Azizur Rahman et al. MOLECULAR NEUROBIOLOGY
- Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions
- (2020) T. T. Favas et al. NEUROLOGICAL SCIENCES
- A role for quercetin in coronavirus disease 2019 (COVID‐19)
- (2020) Giuseppe Derosa et al. PHYTOTHERAPY RESEARCH
- Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis
- (2020) Jarbas da Silva Motta Junior et al. Frontiers in Immunology
- Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients
- (2020) Eric M. Liotta et al. Annals of Clinical and Translational Neurology
- Repositioning microbial biotechnology against COVID‐19: the case of microbial production of flavonoids
- (2020) Tobias Goris et al. Microbial Biotechnology
- Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome
- (2020) Abdul Mannan Baig ACS Chemical Neuroscience
- COVID-19: from an acute to chronic disease? Potential long-term health consequences
- (2020) Victoria Higgins et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- In silico studies reveal antiviral effects of traditional Indian spices on COVID-19
- (2020) Brijesh Kumar et al. CURRENT PHARMACEUTICAL DESIGN
- Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID‐19
- (2020) Brittany Bodnar et al. JOURNAL OF MEDICAL VIROLOGY
- Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
- (2020) Jenny Meinhardt et al. NATURE NEUROSCIENCE
- The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice
- (2020) Elizabeth M. Rhea et al. NATURE NEUROSCIENCE
- The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier
- (2020) Tetyana P. Buzhdygan et al. NEUROBIOLOGY OF DISEASE
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microvascular Injury in the Brains of Patients with Covid-19
- (2020) Myoung-Hwa Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute Cerebrovascular Events With COVID-19 Infection
- (2020) Mandip S. Dhamoon et al. STROKE
- Dietary flavanols improve cerebral cortical oxygenation and cognition in healthy adults
- (2020) Gabriele Gratton et al. Scientific Reports
- Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
- (2020) Yixin Xie et al. Frontiers in Molecular Biosciences
- Potential association of mast cells with coronavirus disease 2019
- (2020) Theoharis C. Theoharides ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression
- (2019) Haiyan Yan et al. Journal of Natural Medicines
- Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?
- (2019) Theoharis C. Theoharides et al. Expert Review of Clinical Immunology
- Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary
- (2019) Spencer Richman et al. CLINICAL THERAPEUTICS
- Brain Injury–Mediated Neuroinflammatory Response and Alzheimer’s Disease
- (2019) Duraisamy Kempuraj et al. NEUROSCIENTIST
- The roles of Flavonoles/Flavonoids in Neurodegeneration and Neuroinflammation
- (2019) Zehra Calis et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Mast Cell Responses to Viruses and Pathogen Products
- (2019) Jean S. Marshall et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome
- (2019) Theoharis C. Theoharides et al. Frontiers in Cellular Neuroscience
- Inhibition of SARS-CoV 3CL protease by flavonoids
- (2019) Seri Jo et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Luteolin Could Improve Cognitive Dysfunction by Inhibiting Neuroinflammation
- (2018) Zhao-Hui Yao et al. NEUROCHEMICAL RESEARCH
- mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders
- (2018) Larisa Ryskalin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review
- (2018) Zeinab Ashaari et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin
- (2018) Alexandra Taracanova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System
- (2018) Ana Clara Liberman et al. NEUROIMMUNOMODULATION
- Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells
- (2017) Arti B. Patel et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Mast cells in neuroinflammation and brain disorders
- (2017) Erik Hendriksen et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons
- (2017) Stephen D. Skaper et al. NEUROSCIENTIST
- A structural mechanism of flavonoids in inhibiting serine proteases
- (2017) Guangpu Xue et al. Food & Function
- Induction of Microglial Activation by Mediators Released from Mast Cells
- (2016) Xiang Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3
- (2016) Avanti Desai et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis
- (2016) Xiang Zhang et al. Journal of Neuroinflammation
- Luteolin protects the hippocampus against neuron impairments induced by kainic acid in rats
- (2016) Tzu Yu Lin et al. NEUROTOXICOLOGY
- Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism
- (2016) Arti B. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dietary Luteolin Reduces Proinflammatory Microglia in the Brain of Senescent Mice
- (2016) Michael D. Burton et al. REJUVENATION RESEARCH
- Antiviral activity of luteolin against Japanese encephalitis virus
- (2016) Wenchun Fan et al. VIRUS RESEARCH
- Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases
- (2015) Lawrence B. Afrin et al. BRAIN BEHAVIOR AND IMMUNITY
- C-kit mutations determine dasatinib mechanism of action in HMC-1 neoplastic mast cells: dasatinib differently regulates PKCδtranslocation in HMC-1560and HMC-1560,816cell lines
- (2015) Araceli Tobío et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells
- (2015) Zuyi Weng et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression
- (2015) A Mayado et al. LEUKEMIA
- Mast Cells, Mastocytosis, and Related Disorders
- (2015) Theoharis C. Theoharides et al. NEW ENGLAND JOURNAL OF MEDICINE
- Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6
- (2015) I Tsilioni et al. Translational Psychiatry
- Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin
- (2015) Theoharis C. Theoharides Frontiers in Neuroscience
- Brain Inflammation, Neuropsychiatric Disorders, and Immunoendocrine Effects of Luteolin
- (2014) Theoharis C. Theoharides et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Identification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening
- (2014) Lin Xu et al. Viruses-Basel
- Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials
- (2014) Serge Gauthier et al. Clinical Interventions in Aging
- An Open-Label Pilot Study of a Formulation Containing the Anti-Inflammatory Flavonoid Luteolin and Its Effects on Behavior in Children With Autism Spectrum Disorders
- (2013) Anilia Taliou et al. CLINICAL THERAPEUTICS
- Ginkgo biloba extract reduces high-glucose-induced endothelial adhesion by inhibiting the redox-dependent interleukin-6 pathways
- (2012) Jia-Shiong Chen et al. Cardiovascular Diabetology
- Evidence for Cognitive Impairment in Mastocytosis: Prevalence, Features and Correlations to Depression
- (2012) Daniela Silva Moura et al. PLoS One
- Mast cell activation syndrome: Proposed diagnostic criteria
- (2010) Cem Akin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease β-amyloid production
- (2008) Kavon Rezai-Zadeh et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression
- (2008) Kavon Rezai-Zadeh et al. Journal of Neuroinflammation
- Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1
- (2008) S. Jang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search